Given its essential role in cytokinesis, emerging studies have increasingly highlighted PRC1’s involvement in tumorigenesis [12, 13], including in the context of NSCLC, where it has been proposed as a promising therapeutic target [14, 15]. Here, PRC1 is linked to non-small cell lung carcinoma.